output
20192025
most citedMachine learning and glioma imaging biomarkers

102 citations

8 papers

cs.AI2025

From artificial to organic: Rethinking the roots of intelligence for digital health

Prajwal Ghimire, Keyoumars Ashkan

The term artificial implies an inherent dichotomy from the natural or organic. However, AI, as we know it, is a product of organic ingenuity: designed, implemented, and iteratively…

eess.IV2025

A generalisable head MRI defacing pipeline: Evaluation on 2,566 meningioma scans

Lorena Garcia-Foncillas Macias, Aaron Kujawa, Aya Elshalakany +2

Reliable MRI defacing techniques to safeguard patient privacy while preserving brain anatomy are critical for research collaboration. Existing methods often struggle with incomplet…

physics.med-ph202475 cited

Proton Resonance Shift Thermometry: A review of modern clinical practices

J. Blackwell, M. J. Krasny, A. O'Brien +4

Magnetic Resonance Imaging (MRI) has become a popular modality in guiding minimally invasive thermal therapies, due to its advanced, non-ionizing, imaging capabilities and its abil…

eess.IV202314 cited

Spatial gradient consistency for unsupervised learning of hyperspectral demosaicking: Application to surgical imaging

Peichao Li, Muhammad Asad, Conor Horgan +3

Hyperspectral imaging has the potential to improve intraoperative decision making if tissue characterisation is performed in real-time and with high-resolution. Hyperspectral snaps…

q-bio.QM20212 cited

Machine Learning and Glioblastoma: Treatment Response Monitoring Biomarkers in 2021

Thomas Booth, Bernice Akpinar, Andrei Roman +10

The aim of the systematic review was to assess recently published studies on diagnostic test accuracy of glioblastoma treatment response monitoring biomarkers in adults, developed…

eess.SP202078 cited

Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using Deep Multiple-Instance Learning

Alexandros Papadopoulos, Konstantinos Kyritsis, Lisa Klingelhoefer +3

Parkinson's Disease (PD) is a slowly evolving neuro-logical disease that affects about 1% of the population above 60 years old, causing symptoms that are subtle at first, but whose…